The Coronavirus disease 2019 (COVID-19) pandemic has grown to be a global public health crisis with no safe and effective treatments available yet. Recent findings suggest that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus pathogen that causes COVID-19, could elicit a cytokine storm that drives edema, dysfunction of the airway exchange, and acute respiratory distress syndrome in the lung, followed by acute cardiac injury and thromboembolic events leading to multiorgan failure and death. Mesenchymal stem cells (MSCs), owing to their powerful immunomodulatory abilities, have the potential to attenuate the cytokine storm and have therefore been proposed as a potential therapeutic approach for which several clinical trials are underway. Given that intravenous infusion of MSCs results in a significant trapping in the lung, MSC therapy could directly mitigate inflammation, protect alveolar epithelial cells, and reverse lung dysfunction by normalizing the pulmonary microenvironment and preventing pulmonary fibrosis. In this review, we present an overview and perspectives of the SARS-CoV-2 induced inflammatory dysfunction and the potential of MSC immunomodulation for the prevention and treatment of COVID-19 related pulmonary disease.

Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm / Song, N.; Wakimoto, H.; Rossignoli, F.; Bhere, D.; Ciccocioppo, R.; Chen, K. -S.; Khalsa, J. K.; Mastrolia, I.; Samarelli, A. V.; Dominici, M.; Shah, K.. - In: STEM CELLS. - ISSN 1066-5099. - 39:6(2021), pp. 707-722. [10.1002/stem.3354]

Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm

Rossignoli F.;Mastrolia I.;Samarelli A. V.;Dominici M.;
2021

Abstract

The Coronavirus disease 2019 (COVID-19) pandemic has grown to be a global public health crisis with no safe and effective treatments available yet. Recent findings suggest that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus pathogen that causes COVID-19, could elicit a cytokine storm that drives edema, dysfunction of the airway exchange, and acute respiratory distress syndrome in the lung, followed by acute cardiac injury and thromboembolic events leading to multiorgan failure and death. Mesenchymal stem cells (MSCs), owing to their powerful immunomodulatory abilities, have the potential to attenuate the cytokine storm and have therefore been proposed as a potential therapeutic approach for which several clinical trials are underway. Given that intravenous infusion of MSCs results in a significant trapping in the lung, MSC therapy could directly mitigate inflammation, protect alveolar epithelial cells, and reverse lung dysfunction by normalizing the pulmonary microenvironment and preventing pulmonary fibrosis. In this review, we present an overview and perspectives of the SARS-CoV-2 induced inflammatory dysfunction and the potential of MSC immunomodulation for the prevention and treatment of COVID-19 related pulmonary disease.
2021
39
6
707
722
Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm / Song, N.; Wakimoto, H.; Rossignoli, F.; Bhere, D.; Ciccocioppo, R.; Chen, K. -S.; Khalsa, J. K.; Mastrolia, I.; Samarelli, A. V.; Dominici, M.; Shah, K.. - In: STEM CELLS. - ISSN 1066-5099. - 39:6(2021), pp. 707-722. [10.1002/stem.3354]
Song, N.; Wakimoto, H.; Rossignoli, F.; Bhere, D.; Ciccocioppo, R.; Chen, K. -S.; Khalsa, J. K.; Mastrolia, I.; Samarelli, A. V.; Dominici, M.; Shah, ...espandi
File in questo prodotto:
File Dimensione Formato  
MSC Covid-19 review 2021_Final.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 2.68 MB
Formato Adobe PDF
2.68 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1239239
Citazioni
  • ???jsp.display-item.citation.pmc??? 26
  • Scopus 45
  • ???jsp.display-item.citation.isi??? 38
social impact